Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
News|Videos|January 19, 2025
Considering Comorbid Symptoms When Addressing ADHD
Key Takeaways
- Individualized medication selection is essential for ADHD, particularly when addressing ancillary symptoms like comorbid anxiety.
- Nonstimulant medications may be preferable for patients with high levels of anxiety.
Ancillary symptoms may be key in guiding treatment management for ADHD.
Advertisement
Ancillary symptoms can help guide medication selection when it comes to attention-deficit/hyperactivity disorder. Michael Asbach, DMSc, PA-C, Psych-CAQ, shared more with Psychiatric Times at the Real Psychiatry conference in Scottsdale, AZ.
For example, for patients with high rates of comorbid anxiety, Asbach might consider a nonstimulant.
"Having individualized choices based on the patient is key," said Asbach.
Mr Asbach is a psychiatric physician associate and serves as associate director of interventional psychiatry at DENT Neurologic Institute in New York.
Advertisement
Related to this article
Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.
Experts highlight biomarker-driven schizophrenia care—computational subtypes, muscarinic drugs, sharper negative-symptom scoring, and KCC2 targets—reducing trial-and-error prescribing.
Panelists explain why precision tools lag in schizophrenia care and highlight simple biomarkers, faster deals, and clinician-industry collaboration.
Early trial shows investigational orexin-2 agonist ALKS 7290 improves adult ADHD symptoms in 14 days, with tolerable safety, paving way for phase 2.
Advertisement
Advertisement
Trending on Psychiatric Times
1
What Clinicians Need to Know About Postpartum Psychosis
2
Brain Trust: Therapeutic Drug Monitoring and Adherence in Schizophrenia, With Jonathan M. Meyer, MD
3
Nature vs Nurture: The Interplay Between Genetics and Environmental Influences
4
AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD
5